Health-related Quality of Life (HRQoL) in Patients With Advanced, Nonfunctional, Well-differentiated Gastrointestinal (GI) or Lung Neuroendocrine Tumors (NET) in the Phase 3 RADIANT-4 Trial

著录项

• 来源
  《Pancreas》 |2017年第3期|共1页
• 作者

  Pavel Marianne E.; Strosberg Jonathan R.; Bubuteishvili-Pacaud Lida; Degtyarev Evgeny; Neary Maureen P.; Hunger Matthias; Eriksson Jennifer; Fazio Nicola; Kulke Matthew; Singh Simron; Yao James C.;

  展开▼
• 作者单位

  Charite Berlin Campus Virchow Klinikum Berlin Germany;

  H Lee Moffitt Canc Ctr &

  Res Inst Tampa FL USA;

  Novartis Pharma AG Basel Switzerland;

  Novartis Pharma AG Basel Switzerland;

  Novartis Pharmaceut Basel Switzerland;

  Mapi Ness Ziona Israel;

  Mapi Ness Ziona Israel;

  IRCCS Ist Europeo Oncol Genoa Italy;

  Dana Farber Canc Inst Boston MA 02115 USA;

  Sunnybrook Hlth Sci Ctr Toronto ON Canada;

  Univ Texas MD Anderson Canc Ctr Houston TX 77030 USA;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 消化系及腹部疾病;
• 关键词